David Einhorn - DME Capital Management
Holding/activity history for Teva Pharmaceutical Industries Ltd. (TEVA)
← All TEVA superinvestors
| Period | Shares | % of Portfolio | Activity | % Change to Portfolio | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| 2026 Q1 | 2,910,729 | 2.75 | Reduce 4.84% | 0.16 | $27.93–37.35 · VW $33.45i | $87,671,158 | SEC |
| 2025 Q4 | 3,058,734 | 3.35 | Reduce 19.05% | 0.57 | $20.11–34.11 · VW $29.43i | $95,463,088 | SEC |
| 2025 Q3 | 3,778,777 | 3.00 | $20.20 | $76,331,295 | SEC | ||
| 2025 Q2 | 3,778,777 | 2.72 | Add 565.04% | 2.31 | $15.38–18.30 · VW $16.38i | $63,332,302 | SEC |
| 2025 Q1 | 568,200 | 0.44 | Add 21.27% | 0.08 | $12.47–17.75 · VW $15.24i | $8,733,234 | SEC |
| 2024 Q4 | 468,550 | 0.53 | Add 44.24% | 0.16 | $16.15–22.80 · VW $18.89i | $10,326,842 | SEC |
| 2024 Q3 | 324,850 | 0.24 | $18.02 | $5,853,797 | SEC | ||
| 2024 Q2 | 324,850 | 0.26 | $16.25 | $5,278,813 | SEC | ||
| 2024 Q1 | 324,850 | 0.21 | Add 21.00% | 0.04 | $11.83–14.47 · VW $13.45i | $4,583,634 | SEC |
| 2023 Q4 | 268,470 | 0.14 | Buy | 0.14 | $8.55–12.64 · VW $11.10i | $2,802,826 | SEC |
Price snapshot:
Current price$32.18
Avg. buy price$16.44
+/- since buy95.79%
52-week low$14.99
52-week high$37.35